TrialThe oncologist2024

Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.

Julia L Glade Bender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.